Viewing StudyNCT04764656



Ignite Creation Date: 2024-05-06 @ 3:48 PM
Last Modification Date: 2024-10-26 @ 1:57 PM
Study NCT ID: NCT04764656
Status: COMPLETED
Last Update Posted: 2024-07-10
First Post: 2021-02-19

Brief Title: Observational Study to Evaluate Fluid Resolution and Effectiveness of Brolucizumab for nAMD in Portugal
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Neovascular Age-related Macular Degeneration nAMD
Keywords:
Name View
fluid resolution View
Beovu View
Brolucizumab View
nAMD View
non-interventional trial View